NM_000251.3:c.138C>A
Variant summary
The NM_000251.3(MSH2):c.138C>A (p.His46Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (★). Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.H46D: Uncertain_significance (ClinVar VariationId 1058599, 1 star); p.H46= (synonymous): Benign/Likely_benign (ClinVar VariationId 491770, 2 stars); p.H46P: Uncertain_significance (ClinVar VariationId 525765, 2 stars); p.H46Q: Likely_benign (ClinVar VariationId 90654, 3 stars); p.H46Y: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 483663) This exact variant is curated in the UniProt human variants database as Uncertain Significance.
Frequency
Consequence
NM_000251.3 missense
Scores
Clinical Significance
Conservation
Publications
- Lynch syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, G2P, Orphanet
- Lynch syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
- mismatch repair cancer syndrome 1Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- mismatch repair cancer syndrome 2Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- Muir-Torre syndromeInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- ovarian cancerInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- malignant pancreatic neoplasmInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- prostate cancerInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- rhabdomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- breast cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
Classification according to ACMG Germline Pathogenicity v2019
Our verdict: Uncertain_significance. The variant received 2 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| PM2Absent/extremely low in population databases | Absent from gnomAD (AD/XL gene) — PM2; Absent from gnomAD at well-covered site (MOI: AD+AR) (base 0.0001, raised to 0.0005 by highest known P/LP ClinVar AF 0.00268) — PM2 moderate. | ||
| PP3Computational evidence supports damaging effect | Germline meta computational scorer (REVEL/MetaRNN/BayesDel) predicts damaging effect — moderate evidence (PP3); Splicing verdict: not pathogenic.; Germline computational verdict: pathogenic (Moderate). | ||
| BP6Reputable source reports benign | ClinVar 1-star benign — moderate (BP6); ClinVar germline classification: Benign/Likely Benign, 1 star(s). |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000251.3. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
MSH2 | MANE Select | c.138C>A p.His46Gln | missense | Exon 1 of 16 | Prot: NP_000242.1 UniProt: | |
MSH2 | c.138C>A p.His46Gln | missense | Exon 1 of 18 | Prot: NP_001393603.1 | ||
MSH2 | c.138C>A p.His46Gln | missense | Exon 1 of 18 | Prot: NP_001393560.1 |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
MSH2 | TSL:1MANE Select | c.138C>A p.His46Gln | missense | Exon 1 of 16 | Prot: ENSP00000233146.2 UniProt: | |
MSH2 | TSL:1 | c.138C>A p.His46Gln | missense | Exon 1 of 16 | Prot: ENSP00000384199.1 UniProt: | |
MSH2 | c.138C>A p.His46Gln | missense | Exon 1 of 17 | Prot: ENSP00000588166.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 3 sources | |||||
GnomAD3 genomes | Cov:33 | ||||
GnomAD4 exome | Cov:31 | ||||
GnomAD4 genome | Cov:33 | ||||
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 26 | |
AlphaMissense | Pathogenic | 0.97 | |
BayesDel_addAF | Pathogenic | 0.46 | D |
BayesDel_noAF | Pathogenic | 0.42 | |
CADD | Uncertain | 25 | |
DANN | Uncertain | 0.99 | |
DEOGEN2 | Pathogenic | 0.88 | D |
Eigen | Uncertain | 0.63 | |
Eigen_PC | Uncertain | 0.53 | |
FATHMM_MKL | Uncertain | 0.94 | D |
FuncVEP CTI | Pathogenic | 0.95 | |
GPN-Star LLR | N/A | -8.7 | |
GPN-Star score | N/A | 8.7 | |
LIST_S2 | Benign | 0.85 | T |
M_CAP | Pathogenic | 0.75 | D |
MetaRNN | Pathogenic | 0.99 | D |
MetaSVM | Pathogenic | 0.89 | D |
Mutation Taster | N/A | 93/7 | polymorphism |
MutationAssessor | Pathogenic | 3.6 | H |
PhyloP100 | Benign | 2.3 | |
popEVE | Benign | -3.6 | |
PrimateAI | Uncertain | 0.78 | T |
PromoterAI | N/A | 0.043 | Neutral |
PROVEAN | Pathogenic | -6.7 | D |
RBP_binding_hub_radar | N/A | 0.97 | |
RBP_regulation_power_radar | N/A | 2.8 | |
REVEL | Pathogenic | 0.89 | |
Sift | Uncertain | 0.0020 | D |
Sift4G | Uncertain | 0.0020 | D |
Varity_R | N/A | 0.98 | |
VESM-3B | Benign | -9.6 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.010 | |
SpliceAI score (max) | Benign | 0.010 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.
MaveDB functional evidence
- Gene
- MSH2
- Assay type
- Cell fitness
- Mechanism
- DNA and Mismatch repair
- Model system
- Immortalized human cells (Homo sapiens)
- Score
- -3.65 · p.His46Gln (assay numbering)